Primary Site >> Colorectal Cancer

Gene >> CD44

  • 1992
  • 1993
  • 1994
  • 1995
  • 1996
  • 1997
  • 1998
  • 1999
  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2.
PMID: 1347918
Ref: Significance of CD44 gene products for cancer diagnosis and disease evaluation.
PMID: 1357452
Ref: CD44 splice variants: expression during lymphocyte activation and tumor progression.
PMID: 7504454
Ref: CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen.
PMID: 7504563
Ref: [CD44, the hyaluronic acid cell receptor. Its role in neoplastic invasion and metastatic dissemination].
PMID: 7515731
Ref: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
PMID: 7691404
Ref: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases.
PMID: 8095628
Ref: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.
PMID: 8416989
Ref: Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.
PMID: 7506122
Ref: Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
PMID: 7510702
Ref: Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen.
PMID: 7513665
Ref: CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
PMID: 7513984
Ref: Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
PMID: 7513991
Ref: H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells.
PMID: 7525057
Ref: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
PMID: 7526103
Ref: [Metastasis-related genes].
PMID: 7526801
Ref: Expression of CD44 splice variants during lymphocyte activation and tumor progression.
PMID: 7530151
Ref: Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer.
PMID: 7537507
Ref: CD44 isoforms in metastatic cancer.
PMID: 7544777
Ref: A novel co-stimulatory T cell antigen co-expressed on renal cell carcinoma.
PMID: 7495750
Ref: Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
PMID: 7530237
Ref: Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis.
PMID: 7534253
Ref: Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.
PMID: 7536236
Ref: Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
PMID: 7538103
Ref: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
PMID: 7539876
Ref: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
PMID: 7539877
Ref: Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.
PMID: 7545538
Ref: Are CD44 variant isoforms involved in human tumour progression?
PMID: 7553660
Ref: Restoration of CD44H expression in colon carcinomas reduces tumorigenicity.
PMID: 7574929
Ref: CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
PMID: 7585612
Ref: MHC class I and class II determinants and some adhesion molecules are engaged in the regulation of nitric oxide production in vitro by human monocytes stimulated with colon carcinoma cells.
PMID: 7586750
Ref: CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants.
PMID: 7591309
Ref: [Expression of CD44 metastatic variant mRNA in colorectal carcinomas and its role in tumor metastasis and invasion].
PMID: 7630010
Ref: [Expression of CD44 alternative splicing variants in lung cancer].
PMID: 7630011
Ref: Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis.
PMID: 7889467
Ref: Identification of CD44 splice variant in Korean colorectal cancers and cell lines.
PMID: 8527042
Ref: Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.
PMID: 8567994
Ref: CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas.
PMID: 8570172
Ref: The modulation of granulomatous tissue and tumour angiogenesis by diclofenac in combination with hyaluronan (HYAL EX-0001).
PMID: 8867646
Ref: Alterations of p53 and k-ras genes in human colorectal-cancer with ulcerative-colitis.
PMID: 21556601
Ref: Expression of messenger-RNA cd44 splice variants in primary colon-cancer and liver metastases.
PMID: 21597863
Ref: Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans.
PMID: 8566581
Ref: CD44 exon variant 6 epitope and hyaluronate synthase are expressed on HT29 human colorectal carcinoma cells in a SCID mouse model of metastasis formation.
PMID: 8605724
Ref: Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues.
PMID: 8608952
Ref: Keratan sulfate modification of CD44 modulates adhesion to hyaluronate.
PMID: 8621620
Ref: Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.
PMID: 8648366
Ref: A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.
PMID: 8654608
Ref: Detection of exfoliated carcinoma cells in colonic luminal washings by identification of deranged patterns of expression of the CD44 gene.
PMID: 8655705
Ref: Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.
PMID: 8695347
Ref: Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
PMID: 8733762
Ref: Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v).
PMID: 8763262
Ref: Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa.
PMID: 8763263
Ref: [Expression of CD44 isoforms--a new histopathologic parameter in colorectal carcinoma?].
PMID: 8767329
Ref: Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44.
PMID: 8769429
Ref: O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells.
PMID: 8858111
Ref: The positive relationship between the expression of CD44 variant 6 and prognosis in colorectal cancer.
PMID: 8883258
Ref: Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors.
PMID: 8893333
Ref: Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms.
PMID: 8909242
Ref: Semiquantitative Detection of Abnormal CD44 Transcripts in Colon Carcinomas by Reverse Transcription-Polymerase Chain Reaction Enzyme-linked Immunosorbant Assay (RT-PCR ELISA).
PMID: 10462557
Ref: CD44 with variant exons 8-10 in colorectal tumors.
PMID: 21544409
Ref: Expression of CD44 splice variants in colorectal cancer.
PMID: 9117309
Ref: Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection.
PMID: 9134429
Ref: Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix.
PMID: 9177905
Ref: Immunophenotyping of human HT29 colon cancer cell primary tumours and their metastases in severe combined immunodeficient mice.
PMID: 9184853
Ref: Detection of circulating tumour cells and nodal metastasis by reverse transcriptase-polymerase chain reaction technique.
PMID: 9189103
Ref: p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesis.
PMID: 9248852
Ref: Expression of CD44, ICAM-1 and N-CAM in colorectal cancer. Correlation with the tumor stage and the phenotypical characteristics of tumor-infiltrating lymphocytes.
PMID: 9252653
Ref: Changes in CD44 expression during carcinogenesis of the mouse colon.
PMID: 9316589
Ref: Soluble protein encoded by CD44 variant exons 8-10 in the serum of patients with colorectal cancer.
PMID: 9361612
Ref: CD44 expression in astrocytic tumors.
PMID: 9436970
Ref: Immunophenotype of human HT29 colon cancer cell metastases in the lungs of scid mice: spontaneous versus artificial metastases.
PMID: 9561026
Ref: Inhibition of liver metastasis formation by anti-CD44 variant exon 9 monoclonal antibody.
PMID: 21528332
Ref: Expression of variant CD44, exon 6 in patients with metastatic pulmonary tumor.
PMID: 21590147
Ref: Molecular changes during the genesis of human gliomas.
PMID: 9407626
Ref: [Molecular diagnosis of gastrointestinal cancers].
PMID: 9474927
Ref: CD44 splice variants as prognostic markers in colorectal cancer.
PMID: 9489913
Ref: CD44 expression in the stromal matrix of colorectal cancer: association with prognosis.
PMID: 9516948
Ref: CD44v6 is not a prognostic factor in primary breast cancer.
PMID: 9541692
Ref: Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
PMID: 9548625
Ref: Acquisition of cell adhesion and induction of focal adhesion kinase of human colon cancer Colo 201 cells by retinoic acid-induced differentiation.
PMID: 9566310
Ref: Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer.
PMID: 9609756
Ref: Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6.
PMID: 9625129
Ref: CD44V6 expression in human colorectal carcinoma.
PMID: 9635685
Ref: Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer.
PMID: 9658313
Ref: Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
PMID: 9721884
Ref: Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resection.
PMID: 9732216
Ref: [Expression of CD44 variant v6 in breast carcinoma and its relationship with other parameters of tumor biology].
PMID: 9732832
Ref: [Expression of variant CD44 in colorectal cancer and its relationship to liver metastasis].
PMID: 9742519
Ref: Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomas.
PMID: 9754757
Ref: Engagement of variant CD44 confers resistance to anti-integrin antibody-mediated apoptosis in a colon carcinoma cell line.
PMID: 9759519
Ref: Expression of cell adhesion molecule CD44 and sialyl Lewis A in gastric carcinoma and colorectal carcinoma in association with hepatic metastasis.
PMID: 9772282
Ref: Multiple intron retention occurs in tumor cell CD44 mRNA processing.
PMID: 9777953
Ref: Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma.
PMID: 9839501
Ref: Differences in the migration capacity of primary human colon carcinoma cells (SW480) and their lymph node metastatic derivatives (SW620).
PMID: 9839620
Ref: No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
PMID: 9849461
Ref: Comparison of CD44 expression in early colorectal carcinomas of the de novo and ex adenoma types.
PMID: 9849854
Ref: Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
PMID: 9893637
Ref: CD44 expression in colorectal cancer.
PMID: 9928409
Ref: Differentiation of a colon cancer cell line on a reconstituted basement membrane in vitro.
PMID: 10319025
Ref: Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
PMID: 10027409
Ref: Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer.
PMID: 10202279
Ref: Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma.
PMID: 10425314
Ref: Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.
PMID: 10471052
Ref: CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins.
PMID: 10485493
Ref: Expression of adhesion molecules in hepatic metastases of colorectal carcinoma: relationship to primary tumours and prognosis after hepatic resection.
PMID: 10530497
Ref: Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction.
PMID: 10551329
Ref: Glycosylation alterations of cells in late phase apoptosis from colon carcinomas.
PMID: 10561459
Ref: Influence of cytokines on the expression of fas ligand and CD44 splice variants in colon carcinoma cells.
PMID: 10567875
Ref: Clinicopathological significance of the expression of CD44v2 in colorectal cancer.
PMID: 10650786
Ref: Prognostic evaluation of metallothionein expression in human colorectal neoplasms.
PMID: 10711249
Ref: [Are there differences between ex adenoma and de novo colorectal carcinomas?].
PMID: 10714204
Ref: [Antigen CD44: does the presence of its isoforms have significance for diagnosis for diagnosis of colorectal cancer?].
PMID: 10786369
Ref: CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value.
PMID: 10549358
Ref: Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma.
PMID: 10648079
Ref: CD44s expression in human colon carcinomas influences growth of liver metastases.
PMID: 10699925
Ref: Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients.
PMID: 10755402
Ref: Do the expression of CD44, apoptosis and thymidylate synthase inhibition rate correlate with the efficacy of chemotherapy in colorectal cancer?
PMID: 10769701
Ref: Expression of CD44, vascular endothelial growth factor, and proliferating cell nuclear antigen in severe venous invasional colorectal cancer and its relationship to liver metastasis.
PMID: 10795863
Ref: Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms.
PMID: 10951334
Ref: Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma.
PMID: 11005492
Ref: Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer.
PMID: 11073815
Ref: The significance of CD44 variants expression in colorectal cancer and its regional lymph nodes.
PMID: 11194197
Ref: Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
PMID: 11149422
Ref: Sodium hyaluronate enhances colorectal tumour cell metastatic potential in vitro and in vivo.
PMID: 11167875
Ref: Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells.
PMID: 11169447
Ref: Age-associated changes in gene expression patterns in the duodenum and colon of rats.
PMID: 11240159
Ref: Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
PMID: 11330579
Ref: [Genetic changes in liver metastasis of colorectal cancer and their clinical application].
PMID: 11393998
Ref: A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells.
PMID: 11431370
Ref: Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44.
PMID: 11447138
Ref: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
PMID: 11470825
Ref: CD44s expression mitigates the phenotype of human colorectal cancer hepatic metastases.
PMID: 11724345
Ref: Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma.
PMID: 11745187
Ref: Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3.
PMID: 11751503
Ref: MRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers.
PMID: 11768609
Ref: CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features.
PMID: 11820582
Ref: Prognostic value of CD44 expression in colorectal carcinomas.
PMID: 11911305
Ref: Beta-catenin--a linchpin in colorectal carcinogenesis?
PMID: 11839557
Ref: Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors.
PMID: 11839564
Ref: Expression of CD44 variants in colorectal carcinoma quantified by real-time reverse transcriptase-polymerase chain reaction.
PMID: 11873246
Ref: Expression of CD44v6 has no prognostic value in patients with colorectal cancer.
PMID: 11961731
Ref: Expression of CD44v5 and -v6 in Barrett's carcinoma is not increased compared to that in nondysplastic Barrett's mucosa.
PMID: 12009784
Ref: CD44v6 is not relevant in colorectal tumour progression.
PMID: 12018451
Ref: TNFalpha and IL-8 regulate the expression and function of CD44 variant proteins in human colon carcinoma cells.
PMID: 12090473
Ref: Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.
PMID: 12145277
Ref: Co-expression of CD44v3 and heparanase is correlated with metastasis of human colon cancer.
PMID: 12165810
Ref: Impact of laparoscopic CO2-insufflation on tumor-associated molecules in cultured colorectal cancer cells.
PMID: 12189480
Ref: Prediction of distant metastasis by using reverse transcriptase-polymerase chain reaction for epithelial and variant CD44 mRNA in the peripheral blood of patients with colorectal cancer.
PMID: 12215164
Ref: Evaluation of clinicopathological factors and the correlation between the adhesion molecule CD44 variant 9 expression and pulmonary metastases from colorectal cancers.
PMID: 12222916
Ref: Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line.
PMID: 12439723
Ref: Impact of laparoscopic and conventional surgery on Kupffer cells, tumor-associated CD44 expression, and intrahepatic tumor spread.
PMID: 12470109
Ref: Expression of CD44s in human colorectal cancer.
PMID: 12515996
Ref: Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas.
PMID: 12560920
Ref: Effect of laparotomy and CO(2) pneumoperitoneum on tumor growth of human colon carcinoma and expression pattern of tumor-associated proteins in the SCID mouse.
PMID: 12684833
Ref: Coprocytobiology: on the nature of cellular elements from stools in the pathophysiology of colonic disease.
PMID: 12702972
Ref: Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
PMID: 12782013
Ref: Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.
PMID: 12854146
Ref: Motility of colon cancer cells: modulation by CD44 isoform expression.
PMID: 14516773
Ref: Evaluation of CD44 variant 6 expression and clinicopathological factors in pulmonary metastases from colon carcinoma.
PMID: 14534711
Ref: CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction.
PMID: 14534719
Ref: [Role of CD44 and MT1-MMP in colorectal cancer invasion and metastasis].
PMID: 14574866
Ref: Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
PMID: 14606105
Ref: Laminin-5 gamma 2 chain and matrix metalloproteinase-2 may trigger colorectal carcinoma invasiveness through formation of budding tumor cells.
PMID: 14666611
Ref: [Effects of sodium hyaluronate on growth and adhesion of two human colorectal cancer cell lines in vitro].
PMID: 14712518
Ref: Osteopontin identified as colon cancer tumor progression marker.
PMID: 14744111
Ref: CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.
PMID: 14654900
Ref: Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.
PMID: 14966921
Ref: Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer.
PMID: 15065603
Ref: Comparative analysis of cell adhesion molecules, cell cycle regulatory proteins, mismatch repair genes, cyclooxygenase-2, and DPC4 in carcinomas arising in inflammatory bowel disease and sporadic colon cancer.
PMID: 15069531
Ref: CD44 negatively regulates apoptosis in murine colonic epithelium via the mitochondrial pathway.
PMID: 15126101
Ref: Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
PMID: 15187109
Ref: CD44 promotes resistance to apoptosis in human colon cancer cells.
PMID: 15215046
Ref: Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
PMID: 15231668
Ref: Expression and localization of membrane-type-1 matrix metalloproteinase, CD 44, and laminin-5gamma2 chain during colorectal carcinoma tumor progression.
PMID: 15517370
Ref: Evaluation of prognosis for malignant rectal gastrointestinal stromal tumor by clinical parameters and immunohistochemical staining.
PMID: 15622586
Ref: Glycoprotein CD44 variant 4 expression in tumour epithelial cells of patients with colorectal cancer.
PMID: 15638368
Ref: Molecule CD44 variant 10 expression in lymphocytes infiltrating tumour tissues and epithelial cells in patients with colorectal cancer.
PMID: 15638386
Ref: CD44s expression in resectable colorectal carcinomas and surrounding mucosa.
PMID: 15641486
Ref: Osteopontin regulates multiple functions contributing to human colon cancer development and progression.
PMID: 15679049
Ref: Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells.
PMID: 15632176
Ref: Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
PMID: 15661802
Ref: Apoptosis and release of CD44s in bleomycin-treated L132 cells.
PMID: 15844216
Ref: Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
PMID: 15871560
Ref: CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
PMID: 15994957
Ref: Gene expression profiling in chemoresistant variants of three cell lines of different origin.
PMID: 16080509
Ref: Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells.
PMID: 16229833
Ref: Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
PMID: 16288042
Ref: Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.
PMID: 16357164
Ref: Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.
PMID: 16177881
Ref: Variant isoforms of CD44 are P- and L-selectin ligands on colon carcinoma cells.
PMID: 16352650
Ref: Profiling of the tetraspanin web of human colon cancer cells.
PMID: 16467180
Ref: HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells.
PMID: 16565092
Ref: Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c-Met and MAPK: functional implications for disease-associated glycosylation changes.
PMID: 16571666
Ref: Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
PMID: 16895556
Ref: Comparison of CD44 expression in primary tumours and metastases of colorectal cancer.
PMID: 16969488
Ref: Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers.
PMID: 17096728
Ref: Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
PMID: 17219742
Ref: Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.
PMID: 17109891
Ref: Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands.
PMID: 17135256
Ref: Surgery-derived reactive oxygen species produced by polymorphonuclear leukocytes promote tumor recurrence: studies in an in vitro model.
PMID: 17196986
Ref: Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors.
PMID: 17273728
Ref: Instillation of taurolidine/heparin after laparotomy reduces intraperitoneal tumour growth in a colon cancer rat model.
PMID: 17337889
Ref: A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
PMID: 17443723
Ref: The role of osteopontin in tumor progression and metastasis in breast cancer.
PMID: 17548669
Ref: Phenotypic characterization of human colorectal cancer stem cells.
PMID: 17548814
Ref: A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression.
PMID: 17579117
Ref: CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation.
PMID: 17599831
Ref: Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy.
PMID: 17945212
Ref: Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells.
PMID: 17945213
Ref: [Identification of colorectal cancer, adenoma, and inflammatory bowel disease specific gene expression patterns using whole genomic oligonucleotide microarray system].
PMID: 17959550
Ref: Interactions between colon cancer cells and hepatocytes in rats in relation to metastasis.
PMID: 18208563
Ref: The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion.
PMID: 18234849
Ref: [Spheres isolated from Colo205 cell line possess cancer stem-like cells under serum-free culture condition].
PMID: 18250051
Ref: Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells.
PMID: 18326857
Ref: Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow.
PMID: 18375392
Ref: L-selectin-mediated lymphocyte-cancer cell interactions under low fluid shear conditions.
PMID: 18385135
Ref: Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
PMID: 18483247
Ref: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
PMID: 18497886
Ref: Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
PMID: 18579572
Ref: Inhibition of fibroblast growth factor 19 reduces tumor growth by modulating beta-catenin signaling.
PMID: 18593907
Ref: Human pancreatic cancer stem cells: implications for how we treat pancreatic cancer.
PMID: 18607507
Ref: Does hyaluronic acid stimulate tumor growth after endoscopic mucosal resection?
PMID: 18637056
Ref: Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer.
PMID: 18661347
Ref: CD133+CD44+ population efficiently enriches colon cancer initiating cells.
PMID: 18663533
Ref: Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.
PMID: 18765800
Ref: Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature.
PMID: 18776587
Ref: CD44 is of functional importance for colorectal cancer stem cells.
PMID: 18980968
Ref: Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene.
PMID: 19034772
Ref: Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
PMID: 19333790
Ref: Biomolecular characterization of CD44-fibrin(ogen) binding: distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen).
PMID: 19004834
Ref: Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer.
PMID: 19010307
Ref: Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
PMID: 19026485
Ref: Characterization of a subpopulation of colon cancer cells with stem cell-like properties.
PMID: 19072981
Ref: Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells.
PMID: 19118161
Ref: Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
PMID: 19246453
Ref: Comparison of cyclooxygenase-2 and CD44 mRNA expression in colorectal cancer and its relevance for prognosis.
PMID: 19277703
Ref: Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth.
PMID: 19321126
Ref: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
PMID: 19336570
Ref: Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
PMID: 19351367
Ref: Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.
PMID: 19360323
Ref: PCDH24-induced contact inhibition involves downregulation of beta-catenin signaling.
PMID: 19383367
Ref: Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.
PMID: 19437567
Ref: Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
PMID: 19451087
Ref: Combination of aging and dimethylhydrazine treatment causes an increase in cancer-stem cell population of rat colonic crypts.
PMID: 19465005
Ref: Higher CO2-insufflation pressure inhibits the expression of adhesion molecules and the invasion potential of colon cancer cells.
PMID: 19522021
Ref: [Galectin-9 isoforms influence the adhesion between colon carcinoma LoVo cells and human umbilical vein endothelial cells in vitro by regulating the expression of E-selectin in LoVo cells].
PMID: 19538882
Ref: Identification, characterization and utilization of tumor cell selectin ligands in the design of colon cancer diagnostics.
PMID: 19581728
Ref: Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness.
PMID: 19603013
Ref: Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
PMID: 19626493
Ref: Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice.
PMID: 19652364
Ref: Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model.
PMID: 19737148
Ref: BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells.
PMID: 19738061
Ref: Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
PMID: 19787202
Ref: Depletion of the proteasome subunit PSMA7 inhibits colorectal cancer cell tumorigenicity and migration.
PMID: 19787246
Ref: The Relationships Between Loss of Standard CD44 Expression and Lymph Node, Liver Metastasis in T3 Colorectal Carcinoma.
PMID: 19937401
Ref: [Cultivation and characterization of tumor spheres generated from human colorectal cancer cell lines].
PMID: 19950614
Ref: Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX.
PMID: 19956394
Ref: New Therapeutics Targeting Colon Cancer Stem Cells.
PMID: 20148131
Ref: The engagement of selectins and their ligands in colorectal cancer liver metastases.
PMID: 19627399
Ref: Cancer stem cells from colorectal cancer-derived cell lines.
PMID: 20133591
Ref: Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers.
PMID: 20176655
Ref: Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
PMID: 20200161
Ref: CD133 expression in rectal cancer after preoperative chemoradiotherapy.
PMID: 20219069
Ref: In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy.
PMID: 20307308
Ref: Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.
PMID: 20332776
Ref: Colon cancer stem cells: promise of targeted therapy.
PMID: 20420952
Ref: Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
PMID: 20433742
Ref: The EpCAM high/CD44 high colorectal carcinoma stem cell phenotype is not preferentially expressed in tumour buds.
PMID: 20459564
Ref: Neem leaf glycoprotein enhances carcinoembryonic antigen presentation of dendritic cells to T and B cells for induction of anti-tumor immunity by allowing generation of immune effector/memory response.
PMID: 20472099
Ref: Apc(MIN) modulation of vitamin D secosteroid growth control.
PMID: 20488884
Ref: Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic properties.
PMID: 20587145
Ref: Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
PMID: 20591218
Ref: Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
PMID: 20606680
Ref: CD133(+) single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential.
PMID: 20617370
Ref: New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.
PMID: 20630067
Ref: The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres.
PMID: 20691072
Ref: Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract.
PMID: 20826154
Ref: Hyaluronan inhibits postchemotherapy tumor regrowth in a colon carcinoma xenograft model.
PMID: 20833754
Ref: Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors.
PMID: 21176222
Ref: Micropatterned surfaces to study hyaluronic acid interactions with cancer cells.
PMID: 21206473
Ref: Molecular identification and targeting of colorectal cancer stem cells.
PMID: 21311095
Ref: Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.
PMID: 21070402
Ref: L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
PMID: 21123622
Ref: Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.
PMID: 21161336
Ref: Colon cancer stem cells: implications in carcinogenesis.
PMID: 21196254
Ref: Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis.
PMID: 21206979
Ref: Hyaluronan-CD44 interactions as potential targets for cancer therapy.
PMID: 21362138
Ref: Expression of cancer stem cell markers CD133 and CD44 in locoregional recurrence of rectal cancer.
PMID: 21378329
Ref: Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma.
PMID: 21473743
Ref: CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
PMID: 21486216
Ref: Single-molecule binding of CD44 to fibrin versus P-selectin predicts their distinct shear-dependent interactions in cancer.
PMID: 21558419
Ref: Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
PMID: 21596996
Ref: Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.
PMID: 21638126
Ref: SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
PMID: 21640118
Ref: Isolation and characterization of spheroid cells from the HT29 colon cancer cell line.
PMID: 21670985
Ref: Direct reprogramming of stem cell properties in colon cancer cells by CD44.
PMID: 21701559
Ref: Enormous influence of TNIK knockdown on intracellular signals and cell survival.
PMID: 21710359
Ref: Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
PMID: 21750907
Ref: Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.
PMID: 21774804
Ref: Common cancer stem cell gene variants predict colon cancer recurrence.
PMID: 21918173
Ref: Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms.
PMID: 21935404
Ref: [The effect of RhoE on CD44 promoter and the malignant behaviors of colorectal cancer cell].
PMID: 22007478
Ref: [Role of CD44(+)/ESA(+) in sorting colonic cancer stem cells].
PMID: 22116729
Ref: Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure.
PMID: 22217990
Ref: Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44.
PMID: 22977525
Ref: Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
PMID: 21509910
Ref: Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
PMID: 21764578
Ref: Immunomodulatory action of dietary fish oil and targeted deletion of intestinal epithelial cell PPARdelta in inflammation-induced colon carcinogenesis.
PMID: 21940900
Ref: Self-assembled nanoparticles of hyaluronic acid/poly(DL-lactide-co-glycolide) block copolymer.
PMID: 22001557
Ref: Direct inhibition of the transforming growth factor-beta pathway by protein-bound polysaccharide through inactivation of Smad2 signaling.
PMID: 22034928
Ref: shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells.
PMID: 22076607
Ref: Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater.
PMID: 22130902
Ref: Cancer stem cell sorting from colorectal cancer cell lines by sedimentation field flow fractionation.
PMID: 22236375
Ref: Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer.
PMID: 22250106
Ref: Colorectal cancer stem cells--hype or real?: comment on "Combined CD133+/CD44+ expression as a prognostic indicator of disease-free survival in patients with colorectal cancer".
PMID: 22250107
Ref: Cultivation and identification of colon cancer stem cell-derived spheres from the Colo205 cell line.
PMID: 22310487
Ref: Bowman-Birk inhibitors, proteasome peptidase activities and colorectal pre neoplasias induced by 1,2-dimethylhydrazine in Swiss mice.
PMID: 22326805
Ref: Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis.
PMID: 22415308
Ref: Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker.
PMID: 22433494
Ref: Establishment of human ovarian serous carcinomas cell lines in serum free media.
PMID: 22445873
Ref: CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
PMID: 22552741
Ref: Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups.
PMID: 22562538
Ref: Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice.
PMID: 22610745
Ref: A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.
PMID: 22670157
Ref: Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cell-cell adhesions.
PMID: 22679508
Ref: Prognostic significance of relevant markers of cancer stem cells in colorectal cancer - a meta analysis.
PMID: 22683959
Ref: Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown.
PMID: 22684815
Ref: Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
PMID: 22711167
Ref: Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.
PMID: 22843930
Ref: Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
PMID: 22895640
Ref: Clinical significance of LGR5 and CD44 expression in locally advanced rectal cancer after preoperative chemoradiotherapy.
PMID: 22923071
Ref: Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells.
PMID: 22927762
Ref: Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells.
PMID: 22959805
Ref: Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
PMID: 22969042
Ref: Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapy.
PMID: 22969903
Ref: Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells.
PMID: 23002207
Ref: miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line.
PMID: 23007737
Ref: PDGF suppresses the sulfation of CD44v and potentiates CD44v-mediated binding of colon carcinoma cells to fibrin under flow.
PMID: 23056168
Ref: Multivariate analysis of molecular indicators for postoperative liver metastasis in colorectal cancer cases.
PMID: 23098501
Ref: Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
PMID: 23151220
Ref: CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
PMID: 23197865
Ref: Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells.
PMID: 23227266
Ref: Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis.
PMID: 22740326
Ref: Transcriptional profiling identifies genes induced by hepatocyte-derived extracellular matrix in metastatic human colorectal cancer cell lines.
PMID: 22930170
Ref: Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer.
PMID: 23055106
Ref: DNA methyltransferase 1 is essential for initiation of the colon cancers.
PMID: 23064049
Ref: Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
PMID: 23076766
Ref: Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFbeta1-targeting peptides P17 and P144.
PMID: 23153552
Ref: Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-kappaB signaling pathways.
PMID: 23170789
Ref: SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.
PMID: 23175153
Ref: Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
PMID: 23230278
Ref: Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer.
PMID: 23251004
Ref: HSP72 and gp96 in gastroenterological cancers.
PMID: 23266770
Ref: Evaluation of alpha 1-antitrypsin and the levels of mRNA expression of matrix metalloproteinase 7, urokinase type plasminogen activator receptor and COX-2 for the diagnosis of colorectal cancer.
PMID: 23300952
Ref: Increased growth of colorectal liver metastasis following partial hepatectomy.
PMID: 23385555
Ref: CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer.
PMID: 23404221
Ref: CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer.
PMID: 23418321
Ref: Sphingosine kinase 1 plays a role in the upregulation of CD44 expression through extracellular signal-regulated kinase signaling in human colon cancer cells.
PMID: 23426175
Ref: A small molecule (pluripotin) as a tool for studying cancer stem cell biology: proof of concept.
PMID: 23437320
Ref: Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells.
PMID: 23450810
Ref: Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.
PMID: 23517721
Ref: Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.
PMID: 23544170
Ref: Clinical significance of CD44 variants expression in colorectal cancer.
PMID: 23549006
Ref: Prognostic role of p53 messenger ribonucleic acid expression in patients after curative resection for stage I to III colorectal cancer: association with colon cancer stem cell markers.
PMID: 23571142
Ref: Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells.
PMID: 23624503
Ref: A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers.
PMID: 23640455
Ref: CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
PMID: 23708747
Ref: Establishment of a human colorectal cancer cell line P6C with stem cell properties and resistance to chemotherapeutic drugs.
PMID: 23736004
Ref: Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6.
PMID: 23751564
Ref: AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer.
PMID: 23752226
Ref: Biochemical and biological characterization of exosomes containing prominin-1/CD133.
PMID: 23767874
Ref: CD44variant exon 9 plays an important role in colon cancer initiating cells.
PMID: 23800986
Ref: Fibronectin extra domain A (EDA) sustains CD133(+)/CD44(+) subpopulation of colorectal cancer cells.
PMID: 23811539
Ref: Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.
PMID: 23874993
Ref: Inhibition of the transcription factor Sp1 suppresses colon cancer stem cell growth and induces apoptosis in vitro and in nude mouse xenografts.
PMID: 23877322
Ref: Progastrin stimulates colonic cell proliferation via CCK2R- and beta-arrestin-dependent suppression of BMP2.
PMID: 23891976
Ref: [Lgr5 and CD44 expressions in different types of intestinal polyps and colorectal cancer].
PMID: 23895835
Ref: Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species.
PMID: 23916687
Ref: [Identification of "side population" associated with cancer stem cells by flow cytometry with violet laser].
PMID: 23987071
Ref: Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.
PMID: 24009080
Ref: CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 status.
PMID: 24009708
Ref: Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.
PMID: 24023782
Ref: Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies.
PMID: 24091671
Ref: Amurensin G enhances the susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity of cancer stem-like cells of HCT-15 cells.
PMID: 24118446
Ref: Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1.
PMID: 24185040
Ref: Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
PMID: 23065858
Ref: Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling.
PMID: 23318432
Ref: Pretreatment expression of 13 molecular markers as a predictor of tumor responses after neoadjuvant chemoradiation in rectal cancer.
PMID: 23787217
Ref: Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.
PMID: 23852449
Ref: Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
PMID: 24145190
Ref: Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.
PMID: 24265293
Ref: Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4.
PMID: 24277698
Ref: ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
PMID: 24327017
Ref: TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.
PMID: 24335200
Ref: Differential effects of 2- and 3-series E-prostaglandins on in vitro expansion of Lgr5+ colonic stem cells.
PMID: 24336194
Ref: MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma.
PMID: 24402783
Ref: Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.
PMID: 24431404
Ref: Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/beta-catenin signaling.
PMID: 24491301
Ref: Patients with CD133-negative colorectal liver metastasis have a poor prognosis after hepatectomy.
PMID: 24554065
Ref: [Cell morphology in the dormancy and proliferation stage of colorectal cancer stem cells].
PMID: 24671820
Ref: Nodal promotes the self-renewal of human colon cancer stem cells via an autocrine manner through Smad2/3 signaling pathway.
PMID: 24696849
Ref: P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer.
PMID: 24708484
Ref: Heated and humidified CO(2) pneumoperitoneum inhibits tumour cell proliferation, migration and invasion in colon cancer.
PMID: 24720439
Ref: Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
PMID: 24760019
Ref: Expression and clinical significance of colorectal cancer stem cell marker EpCAM(high)/CD44(+) in colorectal cancer.
PMID: 24765173
Ref: LGR5 is required for the maintenance of spheroid-derived colon cancer stem cells.
PMID: 24789370
Ref: Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model.
PMID: 24823486
Ref: Immunohistochemical detection of cancer stem cell related markers CD44 and CD133 in metastatic colorectal cancer patients.
PMID: 24864242
Ref: Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
PMID: 24921652
Ref: Prognostic significance of CD44 variant 2 upregulation in colorectal cancer.
PMID: 24921913
Ref: Characterization of side population cells isolated from the colon cancer cell line SW480.
PMID: 24926880
Ref: Decreased camptothecin sensitivity of the stem-cell-like fraction of Caco2 cells correlates with an altered phosphorylation pattern of topoisomerase I.
PMID: 24960044
Ref: Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
PMID: 24975268
Ref: Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer.
PMID: 25013352
Ref: Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture.
PMID: 25075203
Ref: Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT.
PMID: 25238234
Ref: Comparison of putative circulating cancer stem cell detection between the hepatic portal system and peripheral blood in colorectal cancer patients.
PMID: 25368848
Ref: Hypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signaling.
PMID: 25396735
Ref: Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels.
PMID: 25400792
Ref: [Expression of methionine sulfoxide reductase in colorectal cancer stem cells in vitro].
PMID: 25413075
Ref: ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
PMID: 25427584
Ref: Colon cancer: cancer stem cells markers, drug resistance and treatment.
PMID: 25458789
Ref: Inhibition of C-terminal binding protein attenuates transcription factor 4 signaling to selectively target colon cancer stem cells.
PMID: 25483087
Ref: [The differences between three distinct locations of colorectal cancers based on clinicopathological characteristics and molecular features].
PMID: 25619220
Ref: Stem cells, colorectal cancer and cancer stem cell markers correlations.
PMID: 25729599
Ref: HCT116 colonospheres shows elevated expression of hTERT and beta-catenin protein - a short report.
PMID: 25942340
Ref: Autocrine fibroblast growth factor 18 signaling mediates Wnt-dependent stimulation of CD44-positive human colorectal adenoma cells.
PMID: 24619956
Ref: CD58, a novel surface marker, promotes self-renewal of tumor-initiating cells in colorectal cancer.
PMID: 24727892
Ref: Receptor-type protein tyrosine phosphatase kappa directly dephosphorylates CD133 and regulates downstream AKT activation.
PMID: 24882578
Ref: Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc.
PMID: 25017148
Ref: COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cells.
PMID: 25218028
Ref: Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma.
PMID: 25220787
Ref: CD44 functions in Wnt signaling by regulating LRP6 localization and activation.
PMID: 25301071
Ref: Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis.
PMID: 25347154
Ref: Impacts of CD44 knockdown in cancer cells on tumor and host metabolic systems revealed by quantitative imaging mass spectrometry.
PMID: 25461272
Ref: Cytotoxicity of curcumin silica nanoparticle complexes conjugated with hyaluronic acid on colon cancer cells.
PMID: 25511568
Ref: The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells.
PMID: 25535733
Ref: Cancer stem cell marker in circulating tumor cells: expression of CD44 variant exon 9 is strongly correlated to treatment refractoriness, recurrence and prognosis of human colorectal cancer.
PMID: 25550556
Ref: Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1.
PMID: 25565667
Ref: CD44-SLC1A2 fusion transcripts in primary colorectal cancer.
PMID: 25576211
Ref: Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
PMID: 25625240
Ref: Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15.
PMID: 25656374
Ref: LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
PMID: 25665511
Ref: Proteoglycans as potential microenvironmental biomarkers for colon cancer.
PMID: 25715761
Ref: CD44 as a potential diagnostic tumor marker.
PMID: 25737167
Ref: Lithium chloride induces mesenchymaltoepithelial reverting transition in primary colon cancer cell cultures.
PMID: 25738332
Ref: CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
PMID: 25755763
Ref: Metastatic colon cancer cell populations contain more cancer stem-like cells with a higher susceptibility to natural killer cell-mediated lysis compared with primary colon cancer cells.
PMID: 25789015
Ref: Pluripotency transcription factors in the pathogenesis of colorectal cancer and implications for prognosis.
PMID: 25808439
Ref: Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
PMID: 25904505
Ref: The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers.
PMID: 25906747
Ref: Notch-1 promotes stemness and epithelial to mesenchymal transition in colorectal cancer.
PMID: 25914224
Ref: miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
PMID: 25928322
Ref: Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor.
PMID: 25936357
Ref: Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry.
PMID: 25945459
Ref: Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations.
PMID: 26010608
Ref: CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
PMID: 26045788
Ref: Cancer Stem Cell Markers Are Associated With Distant Hematogenous Liver Metastases But Not With Peritoneal Carcinomatosis in Colorectal Cancer.
PMID: 26068177
Ref: Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system.
PMID: 26092596
Ref: Prognostic implications of adhesion molecule expression in colorectal cancer.
PMID: 26097606
Ref: A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
PMID: 26098881
Ref: Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells.
PMID: 26136074
Ref: [Resveratrol inhibits cell proliferation and up-regulates MICA/B expression in human colon cancer stem cells].
PMID: 26146056
Ref: Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis.
PMID: 26161375
Ref: Colorectal cancer-derived tumor spheroids retain the characteristics of original tumors.
PMID: 26185002
Ref: Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
PMID: 26185996
Ref: A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2.
PMID: 26188124
Ref: Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells.
PMID: 26238079
Ref: Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
PMID: 26261008
Ref: Inhibition of CD147 expression by RNA interference reduces proliferation, invasion and increases chemosensitivity in cancer stem cell-like HT-29 cells.
PMID: 26316167
Ref: LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging.
PMID: 26318819
Ref: Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells.
PMID: 26352531
Ref: PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.
PMID: 26399781
Ref: Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and beta-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
PMID: 26408312
Ref: The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear beta-catenin and CD44.
PMID: 26418878
Ref: [Drug resistance of colon cancer cells to 5-fluorouracil mediated by microRNA-21].
PMID: 26418978
Ref: The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
PMID: 26420348
Ref: Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
PMID: 26491300
Ref: Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
PMID: 26552750
Ref: Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy.
PMID: 26569228
Ref: Combination of cetuximab and PP242 synergistically suppress the progression of wild-type KRAS colorectal carcinoma.
PMID: 26586952
Ref: Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line.
PMID: 26634106
Ref: CD44 regulates Wnt signaling at the level of LRP6.
PMID: 27308483
Ref: Isolation of colorectal cancer stem-like cells.
PMID: 25535115
Ref: Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells.
PMID: 25777538
Ref: EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer.
PMID: 26283684
Ref: RNA binding protein RBM3 increases beta-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
PMID: 26331352
Ref: Cancer stem cells in human digestive tract malignancies.
PMID: 26446457
Ref: Clinical influence of cancer stem cells on residual disease after preoperative chemoradiotherapy for rectal cancer.
PMID: 26456957
Ref: Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells.
PMID: 26747179
Ref: Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9(+) cancer stem cells in ulcerative colitis-related cancer.
PMID: 26775891
Ref: Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
PMID: 26785145
Ref: Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
PMID: 26840024
Ref: KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway.
PMID: 26847701
Ref: Self-assembled ternary complexes stabilized with hyaluronic acid-green tea catechin conjugates for targeted gene delivery.
PMID: 26855049
Ref: Curcumin Induces Apoptosis of Colorectal Cancer Stem Cells by Coupling with CD44 Marker.
PMID: 26906122
Ref: Target beta-catenin/CD44/Nanog axis in colon cancer cells by certain N'-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides.
PMID: 26944615
Ref: GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment.
PMID: 26950675
Ref: The Wnt/beta-catenin signaling/Id2 cascade mediates the effects of hypoxia on the hierarchy of colorectal-cancer stem cells.
PMID: 26965643
Ref: Long Non-Coding RNA ucoo2kmd.1 Regulates CD44-Dependent Cell Growth by Competing for miR-211-3p in Colorectal Cancer.
PMID: 26974151
Ref: Role of cancer stem cells in racial disparity in colorectal cancer.
PMID: 26990997
Ref: Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
PMID: 27036131
Ref: Expression Patterns of Cancer Stem Cell Markers During Specific Celecoxib Therapy in Multistep Rat Colon Carcinogenesis Bioassays.
PMID: 27039721
Ref: KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer.
PMID: 27062566
Ref: Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options.
PMID: 27074785
Ref: Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples.
PMID: 27086589
Ref: NIBP impacts on the expression of E-cadherin, CD44 and vimentin in colon cancer via the NF-kappaB pathway.
PMID: 27109343
Ref: Enhanced autophagy in colorectal cancer stem cells does not contribute to radio-resistance.
PMID: 27129175
Ref: Associations between markers of colorectal cancer stem cells, mutation, microRNA and the clinical features of ulcerative colitis.
PMID: 27153478
Ref: Genistein regulates tumor microenvironment and exhibits anticancer effect in dimethyl hydrazine-induced experimental colon carcinogenesis.
PMID: 27255553
Ref: Up-regulation of stem cell markers by P21-activated kinase 1 contributes to 5-fluorouracil resistance of colorectal cancer.
PMID: 27260988
Ref: Combination treatment with flavonoid morin and telomerase inhibitor MST312 reduces cancer stem cell traits by targeting STAT3 and telomerase.
PMID: 27279256
Ref: Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses.
PMID: 27323782
Ref: SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
PMID: 27411517
Ref: Walnut Phenolic Extract and Its Bioactive Compounds Suppress Colon Cancer Cell Growth by Regulating Colon Cancer Stemness.
PMID: 27455311
Ref: Multifunctional Hyaluronic Acid and Chondroitin Sulfate Nanoparticles: Impact of Glycosaminoglycan Presentation on Receptor Mediated Cellular Uptake and Immune Activation.
PMID: 27468113
Ref: Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells.
PMID: 27494849
Ref: Characterization of cancer stem cells from different grades of human colorectal cancer.
PMID: 27507615
Ref: IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells.
PMID: 27533463
Ref: Rab27A mediated by NF-kappaB promotes the stemness of colon cancer cells via up-regulation of cytokine secretion.
PMID: 27556511
Ref: Identification of CD200+ colorectal cancer stem cells and their gene expression profile.
PMID: 27574016
Ref: Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
PMID: 27599396
Ref: GSK-3beta-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.
PMID: 27599658
Ref: Bmi-1 promotes the invasion and migration of colon cancer stem cells through the downregulation of E-cadherin.
PMID: 27600678
Ref: Correlation of multiple proteins with clinic-pathological features and its prognostic significance in colorectal cancer with signet-ring cell component.
PMID: 27608893
Ref: Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer.
PMID: 27650542
Ref: MiR-139-5p reverses CD44+/CD133+-associated multidrug resistance by downregulating NOTCH1 in colorectal carcinoma cells.
PMID: 27738333
Ref: A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.
PMID: 27742685
Ref: CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
PMID: 27764803
Ref: Special AT-rich sequence-binding protein 2 acts as a negative regulator of stemness in colorectal cancer cells.
PMID: 27784965
Ref: A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues.
PMID: 27806848
Ref: Biomarker-Based Scoring System for Prediction of Tumor Response After Preoperative Chemoradiotherapy in Rectal Cancer by Reverse Transcriptase Polymerase Chain Reaction Analysis.
PMID: 27824703
Ref: Novel markers for circulating tumor stem cells in colorectal carcinoma.
PMID: 27830007
Ref: Anti-EGFR antibody sensitizes colorectal cancer stem-like cells to Fluorouracil-induced apoptosis by affecting autophagy.
PMID: 27833077
Ref: Discovery of genes from feces correlated with colorectal cancer progression.
PMID: 27900008
Ref: Inhibiting the SUMO Pathway Represses the Cancer Stem Cell Population in Breast and Colorectal Carcinomas.
PMID: 27916539
Ref: Detection of Cancer Stem Cells in Colorectal Cancer: Histopathological and Immunohistochemical Study.
PMID: 28028388
Ref: Role of Stem Cells in Colorectal Cancer Progression and Prognostic and Predictive Characteristics of Stem Cell Markers in Colorectal Cancer.
PMID: 27593447
Ref: Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
PMID: 27789195
Ref: Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
PMID: 27836735
Ref: Digital gene expression profiling analysis of DNA repair pathways in colon cancer stem population of HT29 cells.
PMID: 27932392
Ref: Pro-metastatic intracellular signaling of the elaidic trans fatty acid.
PMID: 27959384
Ref: CD44-shRNA recombinant adenovirus inhibits cell proliferation, invasion, and migration, and promotes apoptosis in HCT116 colon cancer cells.
PMID: 27959393
Ref: Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and beta-Catenin Signaling.
PMID: 27983919
Ref: The depletion of ATM inhibits colon cancer proliferation and migration via B56gamma2-mediated Chk1/p53/CD44 cascades.
PMID: 28093285
Ref: Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer.
PMID: 28126685
Ref: Gene expression changes in colon tissues from colorectal cancer patients following the intake of an ellagitannin-containing pomegranate extract: a randomized clinical trial.
PMID: 28183047
Ref: Tissue transglutaminase induces Epithelial-Mesenchymal-Transition and the acquisition of stem cell like characteristics in colorectal cancer cells.
PMID: 28223538
Ref: The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer.
PMID: 28237538
Ref: Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in vivo Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets.
PMID: 28255344
Ref: Evaluation of the Role of ALDH1 as Cancer Stem Cell Marker in Colorectal Carcinoma: An Immunohistochemical Study.
PMID: 28273973
Ref: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
PMID: 28341962
Ref: Effect of antitumor drugs in low concentrationson the biological, immunophenotypic and cytogenetic characteristics of human colon cancer cells in vitro.
PMID: 28361849
Ref: Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.
PMID: 28367998
Ref: Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients.
PMID: 28373475
Ref: Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
PMID: 28392690
Ref: Multi-factorial modulation of colorectal carcinoma cells motility - partial coordination by the tetraspanin Co-029/tspan8.
PMID: 28418857
Ref: A novel nanomissile targeting two biomarkers and accurately bombing CTCs with doxorubicin.
PMID: 28422250
Ref: [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
PMID: 28440527
Ref: Knockdown of a DIS3L2 promoter upstream long noncoding RNA (AC105461.1) enhances colorectal cancer stem cell properties in vitro by down-regulating DIS3L2.
PMID: 28496335
Ref: Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice.
PMID: 28499854
Ref: Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.
PMID: 28526879
Ref: Smoothened antagonist GDC-0449 (Vismodegib) inhibits proliferation and triggers apoptosis in colon cancer cell lines.
PMID: 28565875
Ref: Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients.
PMID: 28570747
Ref: AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.
PMID: 28604612
Ref: Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murine.
PMID: 28666099
Ref: Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
PMID: 28677737
Ref: MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
PMID: 28716720
Ref: Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
PMID: 28749462
Ref: A marine bio-functional lipid, fucoxanthinol, attenuates human colorectal cancer stem-like cell tumorigenicity and sphere formation.
PMID: 28751806
Ref: Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
PMID: 28767654
Ref: Acyl-CoA Synthetase 5 Promotes the Growth and Invasion of Colorectal Cancer Cells.
PMID: 28808653
Ref: Osteopontin -- a promising biomarker for cancer therapy.
PMID: 28819419
Ref: Bromopropane Compounds Increase the Stemness of Colorectal Cancer Cells.
PMID: 28862656
Ref: Construction and Evaluation of a Targeted Hyaluronic Acid Nanoparticle/Photosensitizer Complex for Cancer Photodynamic Therapy.
PMID: 28875691
Ref: SATB2/beta-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer.
PMID: 28887549
Ref: Self-assembling HA/PEI/dsRNA-p21 ternary complexes for CD44 mediated small active RNA delivery to colorectal cancer.
PMID: 28994324
Ref: Colorectal carcinoma with osseous metaplasia.
PMID: 29029440
Ref: Roles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells.
PMID: 29064439
Ref: Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis.
PMID: 29105339
Ref: Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
PMID: 29110645
Ref: Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.
PMID: 29167573
Ref: An integrated computational and experimental study uncovers FUT9 as a metabolic driver of colorectal cancer.
PMID: 29196508
Ref: Commensal-infected macrophages induce dedifferentiation and reprogramming of epithelial cells during colorectal carcinogenesis.
PMID: 29254234
Ref: Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells.
PMID: 29312609
Ref: ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway.
PMID: 29348846
Ref: Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer.
PMID: 29383121
Ref: Hyaluronic Acid Layered Chimeric Nanoparticles: Targeting MAPK-PI3K Signaling Hub in Colon Cancer Cells.
PMID: 30023564
Ref: Protein and glycomic plasma markers for early detection of adenoma and colon cancer.
PMID: 27821646
Ref: Ezrin Orchestrates Signal Transduction in Airway Cells.
PMID: 28702704
Ref: Epithelial-mesenchymal transition of tumor budding in colorectal cancer: the mystery of CD44-positive stromal cells.
PMID: 28899739
Ref: Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features.
PMID: 29053388
Ref: Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
PMID: 29115557
Ref: Supramolecular Complex of Methyl-beta-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
PMID: 29269686
Ref: Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
PMID: 29343849
Ref: Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance.
PMID: 29414601
Ref: Anti-inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer.
PMID: 29434827
Ref: Osteopontin-integrin engagement induces HIF-1alpha-TCF12-mediated endothelial-mesenchymal transition to exacerbate colorectal cancer.
PMID: 29435158
Ref: Abrus agglutinin stimulates BMP-2-dependent differentiation through autophagic degradation of beta-catenin in colon cancer stem cells.
PMID: 29457276
Ref: [Coexpression of CD44 and Ki-67 in colon`s neoplast].
PMID: 29460892
Ref: Oligomeric proanthocyanidins (OPCs) target cancer stem-like cells and suppress tumor organoid formation in colorectal cancer.
PMID: 29463813
Ref: Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer.
PMID: 29476264
Ref: Dual targeting system by supramolecular complex of folate-conjugated methyl-beta-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
PMID: 29486262
Ref: Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'-untranslated region in colorectal cancer.
PMID: 29512763
Ref: Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using (18)F-FDG and (18)F-FLT.
PMID: 29571649
Ref: Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
PMID: 29627827
Ref: Revisiting colorectal cancer animal model - An improved metastatic model for distal rectosigmoid colon carcinoma.
PMID: 29628185
Ref: Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.
PMID: 29642386
Ref: [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
PMID: 29690669
Ref: Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
PMID: 29693155
Ref: Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor.
PMID: 29721049
Ref: Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells.
PMID: 29805745
Ref: Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells.
PMID: 29845279
Ref: Ecadherin regulates proliferation of colorectal cancer stem cells through NANOG.
PMID: 29845283
Ref: pH-Responsive hyaluronated liposomes for docetaxel delivery.
PMID: 29902507
Ref: p53 positively regulates the expression of cancer stem cell marker CD133 in HCT116 colon cancer cells.
PMID: 29928431
Ref: A Systems-Level Analysis Reveals Circadian Regulation of Splicing in Colorectal Cancer.
PMID: 29936137
Ref: Resveratrol Chemosensitizes TNF-beta-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
PMID: 30002278
Ref: Evaluation of the correlation of MACC1, CD44, Twist1, and KiSS-1 in the metastasis and prognosis for colon carcinoma.
PMID: 30021598
Ref: pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells.
PMID: 30044910
Ref: Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer.
PMID: 30104575
Ref: The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
PMID: 30136202
Ref: GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcoma.
PMID: 30177521
Ref: Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer.
PMID: 30181548
Ref: LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/beta-catenin pathway and predicts poor survival of glioma patients.
PMID: 30208924
Ref: Effect of Cinnamic acid and FOLFOX in diminishing side population and downregulating cancer stem cell markers in colon cancer cell line HT-29.
PMID: 30209760
Ref: The Molecular Basis of Metastatic Colorectal Cancer.
PMID: 30237756
Ref: Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.
PMID: 30267881
Ref: Solasodine reverses stemness and epithelial-mesenchymal transition in human colorectal cancer.
PMID: 30268504
Ref: FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3beta-related pathways.
PMID: 30275459
Ref: Cancer stem cells in progression of colorectal cancer.
PMID: 30279970
Ref: [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
PMID: 30293346
Ref: The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis.
PMID: 30317669
Ref: Non-target Genes Regulate miRNAs-Mediated Migration Steering of Colorectal Carcinoma.
PMID: 30361904